2Weinshiboum R. Inheritance and drug response[J]. N Engl J Med, 2003, 348(5): 529.
3Guengerich FP. Common and uncommon cytochrome P450reactions related to metabolism and chemical toxicity[J].Chem Res Toxicol, 2001, 14(4): 611.
4Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States[J]. Ann Intern Med, 2002, 135(12): 947.
5Moss AJ. The QT interval and torsades de pointes[J]. Drug Saf, 1999, 21(Supple 1): 5.
6Thummel KE, Slattery JT, Ro H, et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults[J]. Clin Pharmacol Ther, 2000, 67(5):591.
7Reed JC. Apoptosis-regulating proteins as targets for drug discovery[J]. Trends MolMed, 2001, 7(4): 314.
8Pessayre D, Berson A, Fromenty B, et al. Mitochondria in steatohepatitis[J]. Semin Liver Dis, 2001, 21(1): 57.
9Jonsson JR, Edwards-Smith CJ, Catania SC, et al. Expression of cytokines and factors modulating apoptosis by human sinusoidallymphocytes[J]. J Hepatol, 2000, 32(4): 392.
10Huang YS, Chern HD, Su WJ, et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis [ J ]. Hepatology,2002, 35(9): 883.